Deuterated analogs of pridopidine useful as dopaminergic stabilizers
US10799492B2 · kind B2 · utility
0Cited by
6References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 17, 2018 |
| Grant date | Oct 13, 2020 |
| Priority date | — |
| Expiry date | Sep 17, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel deuterated analogs of Pridopidine, i.e. 4-(3-methanesulfonyl-phenyl)-1-propyl-piperidine. Pridopidine is a drug substance currently in clinical development for the treatment of Huntington's disease.In other aspects the invention relates to pharmaceutical compositions comprising a deuterated analog of Pridopidine of the invention, and to therapeutic applications of these analogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.